login
register
Home
Getting Started
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MEDICURE INC (MPH.CA) Stock News
TSX-V:MPH - TSX Venture Exchange -
CA58469E4085
-
Common Stock
- Currency: CAD
0.75
+0.08 (+11.94%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MPH.CA Latest News, Press Relases and Analysis
All
Press Releases
20 days ago - ACCESS Newswire
Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
4 years ago - Medicure Inc.
Medicure Reports Financial Results for the Second Quarter Ended June 30, 2021
4 years ago - Medicure Inc.
Medicure Announces Grant of Stock Options
4 years ago - Medicure Inc.
Medicure Announces Appointment of David Gurvey as Chief Financial Officer
4 years ago - Medicure Inc.
Medicure Reports Financial Results for Quarter Ended March 31, 2021
4 years ago - Medicure Inc.
Medicure 2020 Annual and Q1 2021 Results and Conference Call Date
4 years ago - Medicure Inc.
Medicure Announces Resignation of Chief Financial Officer and Succession Plan
4 years ago - Medicure Inc.
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2020
4 years ago - Medicure Inc.
Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 30, 2021
4 years ago - Medicure Inc.
Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, March 9, 2021
4 years ago - Medicure Inc.
Medicure to Participate in Renmark's Virtual Non-Deal Roadshow Series on Tuesday, February 23, 2021
4 years ago - Medicure Inc.
Medicure To Participate In Renmark's Virtual Non-Deal Roadshow Series on Monday, February 8, 2021
4 years ago - Medicure Inc.
Medicure Announces Early Completion of Enrollment for iSPASM, a Phase 1/2a Exploratory Clinical Trial of AGGRASTAT® (tirofiban hydrochloride) Injection vs. Placebo for Induced Suppression of Platelets Activity in Aneurysmal Subarachnoid Hemorrhage
4 years ago - Medicure Inc.
Medicure Announces Pivotal Phase 3 Trial IND Filing with FDA for Treatment of Seizures Associated with Pyridox(am)ine 5'-phosphate oxidase (PNPO) Deficiency
4 years ago - Medicure Inc.
Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug
4 years ago - Medicure Inc.
Medicure Retains Investor Relations Firm Renmark Financial Communications Inc.
4 years ago - Medicure Inc.
Medicure Announces Settlement of Patent Infringement Action
4 years ago - Medicure Inc.
Medicure Reports Financial Results for Quarter Ended September 30, 2020
4 years ago - Medicure Inc.
Medicure Q3 2020 Results and Conference Call Dates
4 years ago - Medicure Inc.
Medicure announces an agreement with Reliance Life Sciences for the marketing rights of a cardiovascular biosimilar
Please enable JavaScript to continue using this application.